One key study cited that 1.5% of users taking 0.5 mg doses of Ozempic developed gallstones, while another study showed a risk of up to 1.27 times higher for gallbladder conditions when using glucagon-like peptide-1 receptor agonists (GLP-1 RAs), the class of drugs to which Ozempic belongs
All the studies show steady, if slow, improvement in cognitive ability and physical symptoms
Each group consisted of more than 430,000 adults with a diagnosis of type 2 diabetes who had no history of taste or smell impairment
In this article: GLP-1 medications can help you lose weight along with a nutritious and balanced diet
Dialogues Clin Neurosci 2:91100 DeMaagd G, Philip A (2015) Parkinson's disease and Its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis